04/22/2024 3:34 PM | Fairey William (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/22/2024 3:35 PM | Fairey William (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:37 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/08/2024 3:50 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 5:38 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2024 3:35 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) KalVista Pharmaceuticals (Subject)
| Form SC 13G | |
02/22/2024 12:22 PM | Frazier Life Sciences Public Fund, L.P. (Filed by) KalVista Pharmaceuticals (Subject)
| Form SC 13D/A | |
|
02/21/2024 8:51 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:41 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:44 PM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:46 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:48 PM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 3:49 PM | KalVista Pharmaceuticals (Subject) TCG Crossover GP I, LLC (Filed by)
| Form SC 13D/A | |
02/16/2024 3:32 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 3:20 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:21 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:52 PM | KalVista Pharmaceuticals (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024 4:13 PM | KalVista Pharmaceuticals (Filer)
| Form 424B5 | |
02/13/2024 8:11 AM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:20 AM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:23 AM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:06 AM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:08 AM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:55 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 7:30 PM | KalVista Pharmaceuticals (Subject) Saturn V Capital Management LP (Filed by)
| Form SC 13G | |
02/09/2024 8:16 AM | KalVista Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024 7:11 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 3:38 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 6:07 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 7:24 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:02 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 6:04 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 3:26 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 7:57 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 5:05 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:24 PM | KalVista Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/08/2024 3:47 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 3:13 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 5:44 PM | KalVista Pharmaceuticals (Issuer) Koh Bong Y (Reporting) Shah Nimish P (Reporting) Venrock Healthcare Capital Partners EG, L.P. (Reporting) Venrock Healthcare Capital Partners III, L.P. (Reporting) VHCP Co-Investment Holdings III, LLC (Reporting) VHCP Management EG, LLC (Reporting) VHCP Management III, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 3:16 PM | KalVista Pharmaceuticals (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
12/27/2023 4:12 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
The Gold Grab of the Century (Ad) When central banks buy gold…
The rich buy right along with them.
And central banks are buying at breakneck pace.
Last year… 1,037 tons.
Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. |
12/14/2023 12:33 PM | Frazier Life Sciences Public Fund, L.P. (Filed by) KalVista Pharmaceuticals (Subject)
| Form SC 13D/A | |
09/28/2023 3:52 PM | Cha Albert (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 3:53 PM | KalVista Pharmaceuticals (Issuer) Pereira Brian JG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 3:54 PM | KalVista Pharmaceuticals (Issuer) Unkart Edward W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 3:54 PM | KalVista Pharmaceuticals (Issuer) Stuart Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 3:55 PM | KalVista Pharmaceuticals (Issuer) Treanor Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2023 3:29 PM | Cha Albert (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 5:05 PM | Cha Albert (Reporting) KalVista Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:35 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 3:18 PM | KalVista Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/21/2023 7:05 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:05 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:06 PM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:07 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:09 PM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 3:30 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2023 8:37 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4/A | |
05/22/2023 8:39 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4/A | |
05/22/2023 8:40 PM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4/A | |
05/22/2023 8:33 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2023 8:35 PM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4/A | |
05/22/2023 8:36 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4/A | |
05/19/2023 8:18 PM | Feener Edward P. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 8:19 PM | KalVista Pharmaceuticals (Issuer) Palleiko Benjamin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 8:20 PM | KalVista Pharmaceuticals (Issuer) Yea Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 8:16 PM | Audhya Paul K. (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 8:17 PM | Crockett Thomas Andrew (Reporting) KalVista Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |